Belpointe Asset Management’s PAVmed PAVM Stock Holding History

Belpointe Asset Management’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-33	Closed	-$6.12K	–	701
2023 Q2	$6.12K	Sell	33 -178	-84%	-$35.6K	﹤0.01%	611
2023 Q1	$35.5K	Hold	211	–	–	﹤0.01%	1925
2022 Q4	$45.7K	Buy	+211	New	+$79.7K	﹤0.01%	1663
2021 Q4	–	Sell	-78	Closed	-$299K	–	1241
2021 Q3	$299K	Sell	78 -33	-30%	-$104K	0.02%	684
2021 Q2	$320K	Sell	111 -33	-23%	-$78K	0.02%	648
2021 Q1	$289K	Sell	144 -456	-76%	-$686K	0.02%	617
2020 Q4	$572K	Sell	600 -67	-10%	-$57.3K	0.05%	372
2020 Q3	$534K	Sell	667 -66	-9%	-$58.7K	0.06%	321
2020 Q2	$696K	Sell	733 -716	-49%	-$716K	0.09%	229
2020 Q1	$1.29M	Hold	1,449	–	–	0.23%	104
2019 Q4	$782K	Hold	1,449	–	–	0.1%	217
2019 Q3	$625K	Hold	1,449	–	–	0.1%	223
2019 Q2	$743K	Buy	+1,449	New	+$766K	0.15%	151

Other funds holding PAVM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Belpointe Asset Management's PAVM Position: Q3 2023 in Review

Belpointe Asset Management sold out of PAVmed (PAVM) in Q3 2023, closing a stake of 33 shares — an estimated $6.12K sold.

Belpointe Asset Management first reported a position in PAVM in Q2 2019 and held it in 13 quarters. The position peaked at $1.29M in Q1 2020. 60 funds tracked by Wall St. Rank hold PAVM as of Q3 2023.

Belpointe Asset Management reported no remaining PAVmed position as of Q3 2023 after selling out during the quarter.
Belpointe Asset Management sold 33 PAVmed shares in Q3 2023, an estimated $6.12K.
Belpointe Asset Management first reported a position in PAVmed in Q2 2019 and held it in 13 quarters.
Belpointe Asset Management's PAVmed position peaked at $1.29M in Q1 2020.
60 funds tracked by Wall St. Rank held PAVmed as of Q3 2023.

Based on Belpointe Asset Management's 13F filing for Q3 2023, filed 15 Nov 2023.